How much cash does Neuronetics generate?

Neuronetics (STIM) generated -$13.7M in operating cash flow over the trailing twelve months.

What is Neuronetics's free cash flow?

After $779.0K of capital expenditures, Neuronetics's free cash flow was -$14.3M over the trailing twelve months, up 61.7% year over year.

Where does Neuronetics's cash flow data come from?

Every line is extracted from Neuronetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Neuronetics STIM Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Net income	-$39.14M+10.5%	-$43.73M-44.8%	-$30.19M+18.8%	-$37.16M-19.1%
Depreciation and amortization	$3.47M+67.1%	$2.07M+3.3%	$2.01M+21.7%	$1.65M+55.5%
Stock-based compensation	$6.85M+22.2%	$5.6M-23.5%	$7.32M-16.3%	$8.75M+11.1%
Amortization of debt issuance costs	$824K+6.9%	$771K+21.6%	$634K-10.6%	$709K-0.8%
Gain (loss) on sale of assets	——	-$28K—	——	——
Provision for credit losses	——	$2.06M+427%	$390K—	——
Change in accounts receivable	-$3.54M-192%	$3.83M-56.6%	$8.83M+32.6%	$6.66M+74.4%
Change in inventories	——	-$3.15M—	——	$2.77M-19.8%
Change in accounts payable	——	——	——	——
Change in accrued liabilities	——	——	——	$6.6M—
Change in other liabilities	$257K+489%	-$66K—	——	——
Change in deferred revenue	——	-$843K+14.8%	-$989K+21.5%	-$1.26M-686%
Net cash from operating activities	-$21.28M+31.3%	-$31M+9.3%	-$34.17M-11.2%	-$30.74M-9.8%
Capital expenditures	$801K-45.4%	$1.47M-38.1%	$2.37M-27.5%	$3.27M+38.9%
Acquisitions, net of cash acquired	——	$2.55M—	——	——
Proceeds from sale of property, plant and equipment	——	——	——	——
Net cash from investing activities	-$801K+67.0%	-$2.43M-74.9%	-$1.39M-119%	$7.23M+174%
Repayments of debt	——	$60M—	——	——
Proceeds from issuance of common stock	——	$1K0.0%	$1K-99.7%	$298K—
Distributions to noncontrolling interests	$94K—	——	——	——
Other financing activities	$500K—	——	——	——
Net cash from financing activities	$36.88M+642%	-$6.81M—	——	——
Net increase (decrease) in cash	$15.01M+137%	-$40.22M—	——	——
Interest paid	$7.59M+16.6%	$6.51M+36.0%	$4.79M+35.2%	$3.54M+7.2%
Non-cash interest expense	$824K+6.9%	$771K+21.6%	$634K-10.6%	$709K-0.8%
Capitalized software write-off	——	$3.96M—	——	——
Increase Decrease In Net Investment In Sales Type Leases	$31K+103%	-$997K+16.4%	-$1.19M—	——
Increase Decrease In Prepaid Commission Expense	-$958K-187%	$1.1M-16.9%	$1.32M+6.1%	$1.24M-35.5%
Prepaid expenses and other current assets	-$4.67M-505%	$1.16M—	——	——
Inventory write-downs	$388K-38.0%	$626K—	——	——
Accounts Receivable, Credit Loss Expense (Reversal)	——	$2.06M+427%	$390K—	——
Proceeds from disposals of property, plant and equipment	——	——	——	——
Payments Of Debt Extinguishment Costs	——	$4.19M—	——	——
Payments Of Stock Issuance Costs	——	——	——	——
Payments to Noncontrolling Interests	$94K—	——	——	——
Repayments Of Notes Payable	$211K—	——	——	——
Accrued payables for capital expenditures	——	——	——	——
Increase Decrease In Contract With Customer Liability	——	-$843K+14.8%	-$989K+21.5%	-$1.26M-686%
Payment For Contingent Consideration Liability Financing Activities	$500K—	——	——	——
Transfer Of Inventory To Property And Equipment	——	——	$210K—	——
Free cash flow	-$21.87M+32.6%	-$32.46M+9.0%	-$35.66M-4.9%	-$34.01M-12.1%
Free cash flow	-$21.87M+32.6%	-$32.46M+9.0%	-$35.66M-4.9%	-$34.01M-12.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Neuronetics.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

How much cash does Neuronetics generate?: Neuronetics (STIM) generated -$13.7M in operating cash flow over the trailing twelve months.
What is Neuronetics's free cash flow?: After $779.0K of capital expenditures, Neuronetics's free cash flow was -$14.3M over the trailing twelve months, up 61.7% year over year.
Where does Neuronetics's cash flow data come from?: Every line is extracted from Neuronetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.